Page 43 - ITPS-8-2
        P. 43
     INNOSC Theranostics and
            Pharmacological Sciences                                              MDD biomarkers: Clinical implications
            Table 3. miR expression for MDD diagnosis
            Tissue                          miR Expression                 Associated signaling pathways  References
            PBMCs (human)  Upregulated                                    GO, KEGG, and BioCarta        53
                             miR-26b, miR-4743, miR-4498, miR-4485 and miR-1972
            PBMCs (human)  Upregulated                                    Wnt/VEGF/mTOR/ErbB pathways   51
                             miR-26b, miR-1972, miR-4485, miR-4498, and miR-4743
                           Downregulated
                             miR-338
            CSF (human)    Upregulated                                    Serine protein kinases        54
                             miR-125a-5p, miR-30a-5p, let-7d-3p, miR-34a-5p, miR-221-3p,   5HT/CRH/Glu/Wnt/VEGF/mTOR/
                             miR-29b-3p, miR-10a-5p, miR-375, miR-155-5p, miR-33a-5p,   ErbB/LTD pathways
                             miR-139-5p.
                           Downregulated
                             miR-185-5p, miR-590-5p
                             miR-106b-5p, miR-15Bb-5p, miR-451a
            Serum (human)  Upregulated
                             miR-221-3p, miR-34a-5p, let-7d-3p
                           Downregulated
                             miR-451
            CSF and serum   Downregulated                                 Serotonin pathway             55
            (human and rat)  miR-16
            PBMCs          Upregulated                                    Wnt/mTOR/ErbB/insulin/Jak-STAT   56
                             miR-199a-5p, miR-24-3p and miR-425-3p        pathway
                           Downregulated
                             miR-1915-3p, let-7a-5p, let-7d-5p and let-7f-5p
            Blood          Upregulated                                     BRPF1 (required for mouse    57
            (human)          pmiR-chr11, miR-3158-3p, miR-433, miR-3944-5p  hippocampus development)
                           Downregulated
                             miR-1275, miR-4516, miR-30e-3p, miR-148b-3p
            Hippocampus    Downregulated                                  NO and cytokines inflammatory   58
            (mouse)          miR-124                                      pathway
            PBMCs,         Downregulated                                  TLR4 signaling pathway        59
            monocytes        PBMC: let-7e, miR-146a, and miR-155
            (human)          Monocytes: miR-146a and miR-155
                             (Both upregulated after treatment)
            Plasma (human)  Downregulated                                                               60
                             miR-184
            PBMCs (human)  Upregulated                                    CC chemokine receptor activity, T   47
                             ENSG00000238243.3_1, ENSG00000126353.3_2     cell receptor pathways.
                             ENSG00000198034.10_1, ENSG00000254996.5_2
                             ENSG00000184613.10_2, ENSG00000139193.3_2
                             ENSG00000101224.17_1, ENSG00000197153.4_2
                             ENSG00000103064.13_2, ENSG00000256235.1_1
                           Downregulated
                             ENSG00000150991.14_2, ENSG00000172057.9_2
            Plasma (human)  Upregulated                                   Microglial activation pathway  61
            Hippocampus,     miR-134
            PFC (rat)
            Extracellular    Downregulated                                Microglial activation pathway  62
            vesicles         miR-92a-3p
                             miR-129-5p
            PFC              miR-194-5p, miR-25-3p, miR-125-5p            Th17 differentiation in the immune   63
                                                                          system
            Abbreviations: BRPF1: Bromodomain and PHD finger-containing protein 1; CSF: Cerebrospinal fluid; CRH: Corticotropin releasing
            hormone; Glu: Glutamate; lncRNA: Long non-coding RNAs; LTD: Long-term depression; MDD: Major depressive disorder; miR: microRNA;
            mTOR: Mammalian target of rapamycin; NO: Nitric oxide; PBMC: Peripheral blood mononuclear cells; PFC: Prefrontal cortex; VEGF: Vascular
            endothelial growth factor; 5HT: 5 – hydroxyl tryptan.
             Volume 8 Issue 2 (2025)                        37                               doi: 10.36922/itps.4404
     	
